// App-Quantinova.ai

P645 : The introduction of infliximab therapeutic drug level monitoring for is associated with cost savings in a cohort of patients in a large district general hospital

Researchers

Presenter

  • S. Whiteoak

Principal Investigators

  • H. Johnson

  • C. Hovell

  • S. Weaver

  • S. McLaughlin

Medical Centers

  • Royal Bournemouth Hospital, Department of Gastroenterology, Bournemouth, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • Infliximab Biosimilar

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved